Related Experiment Videos
Deconstructing PML-induced premature senescence
Oliver Bischof1, Olivier Kirsh, Mark Pearson
1Unité de Recombinaison et Expression Génétique, INSERM U 163, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.
Abstract:
In this study, we investigated the subcellular and molecular mechanisms underlying promyelocytic leukemia (PML)-induced premature senescence. We demonstrate that intact PML nuclear bodies are not required for the induction of senescence. We have determined further that of seven known PML isoforms, only PML IV is capable of causing premature senescence, providing the first evidence for functional differences among these isoforms. Of interest is the fact that in contrast to PML(+/+) fibroblasts, PML(-/-) cells are resistant to PML IV-induced senescence. This suggests that although PML IV is necessary for this process to occur, it is not sufficient and requires other components for activity. Finally, we provide evidence that PML IV-induced senescence involves stabilization and activation of p53 through phosphorylation at Ser46 and acetylation at Lys382, and that it occurs independently of telomerase and differs from that elicited by oncogenic Ras. Taken together, our data assign a specific pro-senescent activity to an individual PML isoform that involves p53 activation and is independent from PML nuclear bodies.
Insights
Promyelocytic leukemia (PML) isoform IV induces premature senescence by activating p53, independent of PML nuclear bodies. PML-deficient cells resist this senescence, highlighting isoform-specific functions.
Area of Science:
- Cellular senescence
- Molecular biology
- Cancer research
Background:
- Promyelocytic leukemia (PML) protein is implicated in cellular senescence.
- Multiple PML isoforms exist, but their specific roles in senescence are unclear.
- The function of PML nuclear bodies in senescence induction is not fully understood.
Purpose of the Study:
- To elucidate the subcellular and molecular mechanisms of PML-induced premature senescence.
- To identify specific PML isoforms responsible for senescence induction.
- To investigate the role of PML nuclear bodies and p53 in this process.
Main Methods:
- Investigated senescence induction in PML-deficient (PML(-/-)) and wild-type (PML(+/+)) fibroblasts.
- Assessed the role of specific PML isoforms, particularly PML IV, in senescence.
- Analyzed p53 stabilization, phosphorylation (Ser46), and acetylation (Lys382).
Main Results:
- Intact PML nuclear bodies are not required for senescence induction.
- Only PML isoform IV induces premature senescence.
- PML(-/-) cells are resistant to PML IV-induced senescence, indicating a requirement for other cellular components.
- PML IV-induced senescence involves p53 stabilization and activation via specific post-translational modifications.
- Senescence occurs independently of telomerase and oncogenic Ras signaling.
Conclusions:
- Assigns a specific pro-senescent activity to the PML IV isoform.
- PML IV-induced senescence requires p53 activation and is independent of PML nuclear bodies.
- Demonstrates functional divergence among PML isoforms regarding senescence induction.